| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,348 | 4,717 | 4,670 | 4,681 | | Cost of Revenue | 3,113 | 3,910 | 4,247 | 4,432 | | | Gross Profit | 235 | 807 | 423 | 249 | | | Operating Expenses | | Research Development | 1,045 | 1,220 | 861 | 1,031 | | Selling General and Administrative | 3,544 | 4,549 | 2,221 | 2,978 | | Non Recurring |
-
|
-
| 867 |
-
| | Others |
-
|
-
| (285) | 56 | | | | Total Operating Expenses |
-
|
-
| 3,664 |
-
| | | | Operating Income or Loss | (4,354) | (4,962) | (3,241) | (3,816) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (589) | 73 | 94 | (38) | | Earnings Before Interest And Taxes | (4,943) | (4,889) | (3,147) | (3,854) | | Interest Expense | 1,250 | 1,265 | 1,222 | 1,298 | | Income Before Tax | (6,193) | (6,154) | (4,369) | (5,152) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,193) | (6,154) | (4,369) | (5,152) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,193) | (6,154) | (4,369) | (5,152) | | Preferred Stock And Other Adjustments | (43) | (43) | (42) | (44) | | | Net Income Applicable To Common Shares | ($6,236) | ($6,197) | ($4,411) | ($5,196) |
|
0.51% Nasdaq 
0.04 (3.59%) 
Income Statement
